Recently, wedemonstrated the high efficiency of the therapy based on the recombinantSLURP-1 in controlling SCC cell growth and metastasis in vivo.The anti-tumor effect of SLURP-1 was mediated through interaction with bothα7-nAChR and the epidermal growth factor receptor (EGFR). Here, CHRNA4 is linked to neoplasm.